Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol during spinal surgery: effects on evoked potentials
ChiCTR2600117657Phase 4Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Spinal Cord Abnormalities and Back disorder (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Motor Evoked Potentials Amplitude. Started Jan 2026; status: recruiting.
02
Drugs
remimazolam
03
Conditions
Spinal Cord AbnormalitiesBack disorder
Beyond the preview
Go deeper on ChiCTR2600117657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117657.